AGL vs. TOI

The year-to-date returns for both stocks are quite close, with AGL having a 110.53% return and TOI slightly lower at 110.32%.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for agilon health, inc. (AGL) and The Oncology Institute, Inc. (TOI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current AGL Sharpe Ratio is -0.35, which is comparable to the TOI Sharpe Ratio of -0.50. The chart below compares the historical Sharpe Ratios of AGL and TOI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither AGL nor TOI has paid dividends to shareholders.

The maximum AGL drawdown since its inception was -96.37%, roughly equal to the maximum TOI drawdown of -98.79%. Use the drawdown chart below to compare losses from any high point for AGL and TOI. For additional features, visit the drawdowns tool.

The current volatility for agilon health, inc. (AGL) is 20.72%, while The Oncology Institute, Inc. (TOI) has a volatility of 36.41%. This indicates that AGL experiences smaller price fluctuations and is considered to be less risky than TOI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between agilon health, inc. and The Oncology Institute, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.